Evommune, Inc. (EVMN) is a publicly traded the market company. As of August 26, 2026, EVMN trades at $13.78 with a market cap of $496.11M and a P/E ratio of -1.22. EVMN moved +0.88% today. Year to date, EVMN is -20.34%; over the trailing twelve months it is flat. Its 52-week range spans $10.47 to $33.20. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces EVMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Evommune, Inc. (EVMN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EVMN moved +0.88% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $13.78 |
| Market Cap | $496.11M |
| P/E Ratio | -1.22 |
| EPS | $-11.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.20 |
| 52-Week Low | $10.47 |
| Volume | 319.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.00M |
| Net Income | $-68.87M |
| Gross Margin | 0.00% |
7 analysts cover EVMN: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.00.